No Data
Hang Seng Index: Benefiting from policy support, biotechnology stocks have seen three consecutive months of inflows.
The Hang Seng Index company stated that there are signs of improvement in the recent situation of biotechnology stocks, as well as benefitting from policy support and three consecutive months of inflow of funds.
King International Investment Swings to Profit in Fiscal Year 2024
KING INTL INV: ANNUAL REPORT 2024
Emperor International Investments (00928) has announced its annual performance, with a net profit attributable to shareholders of HKD 15.818 million, a year-on-year reversal from loss to profit.
Emperor International Investment (00928) released its annual results for the year ending March 31, 2024, with the group generating a revenue of 2...
Express News | King International Investment FY Revenue HKD 233.68 Million
Express News | King International Investment FY Gross Margin 16.17%
No Data
